CareDx Inc. revises revenue guidance for the full year ended December 31, 2023. For the period, the company expects revenue to be in the range of $279 million to $280 million, which is above the high end of guidance for fiscal year 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.48 USD | +0.66% | +3.98% | +21.83% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.83% | 751M | |
-40.39% | 8.21B | |
+7.82% | 3.55B | |
-0.74% | 2.24B | |
-26.02% | 1.86B | |
-20.94% | 1.68B | |
+10.23% | 940M | |
-12.45% | 667M | |
-1.89% | 286M | |
-24.76% | 143M |
- Stock Market
- Equities
- CDNA Stock
- News CareDx, Inc
- CareDx, Inc Revises Revenue Guidance for the Full Year Ended December 31, 2023